Valeo Financial Advisors, LLC Abbott Laboratories Transaction History

Valeo Financial Advisors, LLC

  • $3.49 Billion
  • Q2 2024

A detailed history of Valeo Financial Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 31,917 shares of ABT stock, worth $3.59 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
31,917
Previous 30,746 3.81%
Holding current value
$3.59 Million
Previous $3.49 Million 5.09%
% of portfolio
0.09%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024
BUY
$100.73 - $112.44 $117,954 - $131,667
1,171 Added 3.81%
31,917 $3.32 Million
Q1 2024

Apr 25, 2024
SELL
$109.52 - $120.96 $14,237 - $15,724
-130 Reduced 0.42%
30,746 $3.49 Million
Q1 2024

Apr 19, 2024
BUY
$109.52 - $120.96 $34,827 - $38,465
318 Added 1.04%
30,876 $3.51 Million
Q4 2023

Jan 29, 2024
BUY
$90.19 - $110.4 $589,572 - $721,684
6,537 Added 27.21%
30,558 $3.36 Million
Q3 2023

Oct 19, 2023
SELL
$95.53 - $114.62 $175,393 - $210,442
-1,836 Reduced 7.1%
24,021 $2.33 Million
Q2 2023

Jul 14, 2023
SELL
$100.78 - $112.29 $54,320 - $60,524
-539 Reduced 2.04%
25,857 $2.82 Million
Q1 2023

Apr 17, 2023
BUY
$96.86 - $114.01 $172,410 - $202,937
1,780 Added 7.23%
26,396 $2.67 Million
Q4 2022

Feb 09, 2023
SELL
$95.06 - $111.52 $33,271 - $39,032
-350 Reduced 1.4%
24,616 $2.7 Million
Q3 2022

Oct 31, 2022
BUY
$96.76 - $112.03 $435,420 - $504,135
4,500 Added 21.99%
24,966 $2.42 Million
Q2 2022

Aug 03, 2022
SELL
$102.07 - $123.37 $336,831 - $407,121
-3,300 Reduced 13.89%
20,466 $2.22 Million
Q1 2022

Apr 28, 2022
BUY
$114.02 - $139.04 $356,084 - $434,221
3,123 Added 15.13%
23,766 $2.81 Million
Q4 2021

Jan 07, 2022
SELL
$115.53 - $141.46 $153,539 - $188,000
-1,329 Reduced 6.05%
20,643 $2.91 Million
Q3 2021

Nov 02, 2021
BUY
$116.66 - $129.06 $227,020 - $251,150
1,946 Added 9.72%
21,972 $2.6 Million
Q2 2021

Jul 22, 2021
SELL
$105.79 - $124.53 $866,631 - $1.02 Million
-8,192 Reduced 29.03%
20,026 $2.32 Million
Q1 2021

Apr 12, 2021
BUY
$108.84 - $128.23 $31,672 - $37,314
291 Added 1.04%
28,218 $3.38 Million
Q4 2020

Feb 11, 2021
BUY
$105.0 - $114.42 $933,450 - $1.02 Million
8,890 Added 46.7%
27,927 $3.06 Million
Q3 2020

Oct 28, 2020
SELL
$91.64 - $111.29 $60,115 - $73,006
-656 Reduced 3.33%
19,037 $2.07 Million
Q2 2020

Jul 20, 2020
SELL
$76.57 - $98.0 $22,894 - $29,302
-299 Reduced 1.5%
19,693 $1.8 Million
Q1 2020

Apr 13, 2020
SELL
$62.82 - $91.86 $95,926 - $140,270
-1,527 Reduced 7.1%
19,992 $1.72 Million
Q4 2019

Jan 24, 2020
BUY
$78.51 - $87.4 $97,195 - $108,201
1,238 Added 6.1%
21,519 $1.87 Million
Q3 2019

Oct 15, 2019
SELL
$81.84 - $88.74 $151,158 - $163,902
-1,847 Reduced 8.35%
20,281 $1.7 Million
Q2 2019

Jul 10, 2019
BUY
$72.88 - $85.0 $20,479 - $23,885
281 Added 1.29%
22,128 $1.86 Million
Q1 2019

Apr 12, 2019
BUY
$66.22 - $80.06 $79,000 - $95,511
1,193 Added 5.78%
21,847 $1.75 Million
Q4 2018

Jan 30, 2019
SELL
$65.56 - $74.27 $2,294 - $2,599
-35 Reduced 0.17%
20,654 $1.49 Million
Q3 2018

Nov 01, 2018
BUY
$60.81 - $73.36 $140,349 - $169,314
2,308 Added 12.56%
20,689 $1.42 Million
Q2 2018

Aug 14, 2018
BUY
$57.57 - $63.54 $105,640 - $116,595
1,835 Added 11.09%
18,381 $1.17 Million
Q1 2018

Apr 12, 2018
SELL
$56.27 - $63.62 $90,763 - $102,619
-1,613 Reduced 8.88%
16,546 $991,000
Q4 2017

Feb 09, 2018
BUY
$53.68 - $57.47 $10,252 - $10,976
191 Added 1.06%
18,159 $1.04 Million
Q3 2017

Nov 14, 2017
BUY
$48.06 - $53.64 $863,542 - $963,803
17,968
17,968 $959,000

Others Institutions Holding ABT

# of Institutions
3,135
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.17M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email